[PHARMA] Risk Committee REDESIGNATION - SARAH AZREEN BINTI ABDUL SAMAT on 27-Mar-2024
Announcement Date
27-Mar-2024
Risk Committee Information:
Date of Change
27-Mar-2024
Type of Change
REDESIGNATION
Designation
Risk Committee
Directorate
Independent and Non Executive
Age
48
Gender
Female
Nationality
Malaysia
Composition
1. Dato' Mohd Zahir bin Zahur Hussain (Independent Non-Executive Director) (Chairman) 2. Sarah Azreen binti Abdul Samat (Independent Non-Executive Director) (Member) 3. Ahmad Shahredzuan bin Mohd Shariff (Non-Independent Non-Executive Director) (Member) 4. Dr. Abdul Razak bin Ahmad (Senior Independent Non-Executive Director) (Member) 5. Dato' Dr Faridah Aryani binti Md Yusof (Independent Non-Executive Director) (Member)
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
MQ Trading Signals
Time
Signal
Duration
Type
2024-04-26 16:40:00
EMA 5
10 Mins
BUY
2024-04-26 16:40:00
EMA 5
5 Mins
BUY
2024-04-26 16:40:00
ADX
5 Mins
SELL
2024-04-26 16:40:00
VOLUME BREAKOUT
5 Mins
BUY
2024-04-26 16:35:00
ADX
5 Mins
BUY
Apps
Top Articles
2
save malaysia!
3
RHB Investment Research Reports
5
6
7
8
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
